FDx Advisors Inc. acquires shares of 2,508 Amdocs Limited (NASDAQ:DOX)

FDx Advisors Inc. acquired a new stake in shares of Amdocs Limited (NASDAQ:DOX – Get Rating) in the first quarter, reports HoldingsChannel.com. The fund acquired 2,508 shares of the technology company, valued at around $206,000.

A number of other institutional investors have also increased or reduced their stakes in DOX. JFS Wealth Advisors LLC increased its stake in Amdocs by 58.0% in Q1. JFS Wealth Advisors LLC now owns 425 shares of the technology company valued at $35,000 after buying an additional 156 shares in the last quarter. Denali Advisors LLC increased its stake in Amdocs by 33.3% during the 1st quarter. Denali Advisors LLC now owns 800 shares of the technology company valued at $66,000 after buying an additional 200 shares last quarter. Quadrant Capital Group LLC increased its stake in Amdocs by 39.5% during the fourth quarter. Quadrant Capital Group LLC now owns 1,346 shares of the technology company valued at $101,000 after buying 381 additional shares last quarter. Wahed Invest LLC acquired a new stake in Amdocs during Q4, valued at approximately $116,000. Finally, Exchange Traded Concepts LLC acquired a new stake in Amdocs during Q1 worth approximately $132,000. 87.09% of the shares are held by hedge funds and other institutional investors.

Changes to analyst ratings

A number of research analysts have weighed in on DOX stocks recently. StockNews.com upgraded Amdocs shares from a “buy” rating to a “strong buy” rating in a report on Tuesday, May 24. Citigroup reduced its target price on Amdocs shares from $93.00 to $90.00 in a report Thursday, May 12. Finally, Oppenheimer reissued a “top pick” rating on Amdocs stock in a Friday, May 13, report.

Amdocs stock up 0.4%

Shares of DOX opened at $87.06 on Friday. The company has a market capitalization of $11.41 billion, a PE ratio of 19.52, a P/E/G ratio of 1.79 and a beta of 0.69. The company has a fifty-day moving average of $83.82 and a 200-day moving average of $81.29. Amdocs Limited has a 52 week low of $68.33 and a 52 week high of $88.18. The company has a quick ratio of 1.50, a current ratio of 1.50 and a debt ratio of 0.23.

Amdocs (NASDAQ:DOX – Get Rating) last released its quarterly results on Wednesday, May 11. The technology company reported earnings per share (EPS) of $1.43 for the quarter, beating analyst consensus estimates of $1.12 by $0.31. The company posted revenue of $1.15 billion in the quarter, versus a consensus estimate of $1.12 billion. Amdocs had a return on equity of 16.78% and a net margin of 12.76%. During the same period last year, the company earned earnings per share of $1.05. On average, sell-side analysts expect Amdocs Limited to post EPS of 4.77 for the current year.

Amdocs Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, July 29. Investors of record on Thursday, June 30 received a dividend of $0.395. The ex-dividend date was Wednesday, June 29. This represents a dividend of $1.58 on an annualized basis and a yield of 1.81%. Amdocs’ dividend payout ratio is currently 35.43%.

Amdocs Company Profile

(Get an evaluation)

Amdocs Limited, through its subsidiaries, provides software and services worldwide. The company designs, develops, operates, implements, supports and markets an open and modular cloud portfolio. It provides CES21, an industry-leading customer experience suite powered by 5G and cloud-native microservices that enables service providers to build, deliver and monetize advanced services; the Commerce and Care Suite for capturing, managing and engaging customers; monetization suite for billing, invoicing, policies and revenue management; Intelligent networking suite with a set of modular, flexible and open service lifecycle management capabilities for network automation journeys; MarketONE, a cloud-native enterprise ecosystem; Digital Brands Suite, a pre-integrated digital business suite for digital telecommunications brands and small service providers; and eSIM Cloud for service providers.

Featured Articles

Want to see which other hedge funds hold DOX? Visit HoldingsChannel.com for the latest 13F filings and insider trading for Amdocs Limited (NASDAQ:DOX – Get Rating).

Institutional ownership by quarter for Amdocs (NASDAQ:DOX)

Get news and reviews for Amdocs Daily – Enter your email address below to receive a concise daily summary of breaking news and analyst ratings for Amdocs and related companies with MarketBeat.com’s FREE daily newsletter.

About Catriona

Check Also

Nemaura receives a provisional purchase order from Middle

LOUGHBOROUGH, ENGLAND, Oct. 12, 2022 (GLOBE NEWSWIRE) — Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or …